SCHEMBL19278352

SCHEMBL19278352

COc1ccc(N(C)c2ccc(CO)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 1/20 0.46
▸ IDO1 P14902 2/20 0.45
▸ HTT P42858 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ALOX5 P09917 1/20 0.44
▸ CALM1 P0DP23 2/20 0.43
▸ SLC2A1 P11166 1/20 0.43
▸ LTA4H P09960 2/20 0.42
▸ AGXT P21549 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ TUBB4A P04350 2/20 0.42
▸ TUBB P07437 2/20 0.42
▸ TUBA3C P0DPH7 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13821929 0.86 IDO1 (0.47) AOC3IDO1HTTALDH1A1SMN1; SMN2
SCHEMBL12732320 0.86 IDO1 (0.47) AOC3IDO1HTTALDH1A1SMN1; SMN2
SCHEMBL3929503 0.86 IDO1 (0.47) AOC3IDO1HTTALDH1A1SMN1; SMN2
SCHEMBL10062238 0.86 IDO1 (0.47) AOC3IDO1HTTALDH1A1SMN1; SMN2
SCHEMBL4181089 0.85 IDO1 (0.58) IDO1HTTALDH1A1SMN1; SMN2CALM1
SCHEMBL27329 0.85 IDO1 (0.58) IDO1HTTALDH1A1SMN1; SMN2CALM1
SCHEMBL11310810 0.85 TSHR (0.44) ALDH1A1LTA4HCA12CA1CA2
SCHEMBL1475480 0.83 IDO1 (0.56) IDO1HTTALDH1A1SMN1; SMN2CALM1
Methyl Alcohol SCHEMBL28311094 0.83 IDO1 (0.56) IDO1HTTALDH1A1SMN1; SMN2CALM1
Methoxymethane SCHEMBL28284584 0.83 IDO1 (0.56) IDO1HTTALDH1A1SMN1; SMN2CALM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-11758809-B2 Compound, display panel, and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-09-12 — — US disclosed
US-20190055212-A1 HISTONE DEMETHYLASE INHIBITORS GWALTNEY STEPHEN (US) 2019-02-21 — — US disclosed
WO-2017143011-A1 HISTONE DEMETHYLASE INHIBITORS Chrysalis, Inc. (US) 2017-08-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190055212-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM6B, KDM5B AOC3 4067/4885IDO1 1515/4885HTT 2249/4885
US-11780831-B2 Compound, display panel and display apparatus C1S, DRD1, DRD3 AOC3 413/4885IDO1 1146/4885HTT 3931/4885
US-11758809-B2 Compound, display panel, and display apparatus C1S, C3AR1, DRD3 AOC3 1367/4885IDO1 2878/4885HTT 2790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback